Adcock Ingram Holdings Ltd banner
A

Adcock Ingram Holdings Ltd
JSE:AIP

Watchlist Manager
Adcock Ingram Holdings Ltd
JSE:AIP
Watchlist
Price: 7 480.0003 Zac Market Closed
Market Cap: 12.1B ZAR

Relative Value

The Relative Value of one AIP stock under the Base Case scenario is hidden Zac. Compared to the current market price of 7 480.0003 Zac, Adcock Ingram Holdings Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AIP Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

AIP Competitors Multiples
Adcock Ingram Holdings Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ZA
Adcock Ingram Holdings Ltd
JSE:AIP
12.1B ZAR 1.2 14.1 9 10.6
US
Eli Lilly and Co
NYSE:LLY
879B USD 13.5 42.6 28.7 30.7
US
Johnson & Johnson
NYSE:JNJ
573.4B USD 6.1 21.4 14.9 18.3
CH
Roche Holding AG
SIX:ROG
256.6B CHF 4.2 19.9 11.8 13.3
CH
Novartis AG
SIX:NOVN
233.8B CHF 5.4 21.6 13.3 17.1
UK
AstraZeneca PLC
LSE:AZN
222.9B GBP 5.1 29.2 16.2 22.8
US
Merck & Co Inc
NYSE:MRK
286.7B USD 4.4 15.7 9.7 11.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 11 8.1 9.5
US
Pfizer Inc
NYSE:PFE
156.1B USD 2.5 20.1 7.7 10.3
US
Bristol-Myers Squibb Co
NYSE:BMY
120.2B USD 2.5 17.1 7.2 8.8
P/E Multiple
Earnings Growth PEG
ZA
A
Adcock Ingram Holdings Ltd
JSE:AIP
Average P/E: 21.3
14.1
6%
2.3
US
Eli Lilly and Co
NYSE:LLY
42.6
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
21.4
7%
3.1
CH
Roche Holding AG
SIX:ROG
19.9
14%
1.4
CH
Novartis AG
SIX:NOVN
21.6
14%
1.5
UK
AstraZeneca PLC
LSE:AZN
29.2
26%
1.1
US
Merck & Co Inc
NYSE:MRK
15.7
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
US
Pfizer Inc
NYSE:PFE
20.1
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.1
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ZA
A
Adcock Ingram Holdings Ltd
JSE:AIP
Average EV/EBITDA: 42.9
9
5%
1.8
US
Eli Lilly and Co
NYSE:LLY
28.7
22%
1.3
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.4
CH
Roche Holding AG
SIX:ROG
11.8
6%
2
CH
Novartis AG
SIX:NOVN
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
16.2
13%
1.2
US
Merck & Co Inc
NYSE:MRK
9.7
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.1
1%
8.1
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett